KMS Medisurgi Ltd
BSE:540468
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
KMS Medisurgi Ltd
BSE:540468
|
IN |
|
Synaptics Inc
NASDAQ:SYNA
|
US |
|
Beijing Wandong Medical Technology Co Ltd
SSE:600055
|
CN |
Balance Sheet
Balance Sheet Decomposition
KMS Medisurgi Ltd
KMS Medisurgi Ltd
Balance Sheet
KMS Medisurgi Ltd
| Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
4
|
4
|
4
|
4
|
13
|
14
|
15
|
12
|
3
|
6
|
4
|
2
|
4
|
5
|
|
| Cash |
4
|
4
|
4
|
4
|
13
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
14
|
15
|
12
|
3
|
6
|
4
|
2
|
4
|
5
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
17
|
23
|
35
|
35
|
45
|
44
|
51
|
53
|
56
|
64
|
69
|
66
|
63
|
43
|
|
| Accounts Receivables |
10
|
21
|
30
|
31
|
38
|
40
|
47
|
51
|
55
|
63
|
65
|
65
|
58
|
42
|
|
| Other Receivables |
8
|
2
|
5
|
4
|
7
|
4
|
4
|
3
|
2
|
1
|
3
|
1
|
6
|
1
|
|
| Inventory |
1
|
1
|
4
|
10
|
3
|
1
|
13
|
18
|
14
|
7
|
10
|
9
|
21
|
25
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Current Assets |
23
|
28
|
43
|
50
|
61
|
59
|
80
|
83
|
73
|
77
|
82
|
77
|
89
|
73
|
|
| PP&E Net |
6
|
13
|
27
|
23
|
20
|
27
|
22
|
22
|
18
|
16
|
15
|
18
|
16
|
17
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
8
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
12
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
|
| Total Assets |
36
N/A
|
46
+27%
|
70
+52%
|
72
+3%
|
81
+12%
|
86
+7%
|
102
+19%
|
105
+3%
|
91
-14%
|
93
+2%
|
98
+5%
|
97
-1%
|
109
+12%
|
103
-5%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
6
|
10
|
18
|
31
|
24
|
22
|
21
|
29
|
15
|
18
|
21
|
13
|
25
|
12
|
|
| Short-Term Debt |
1
|
2
|
19
|
8
|
15
|
19
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
2
|
1
|
1
|
1
|
2
|
1
|
1
|
2
|
1
|
1
|
0
|
2
|
1
|
1
|
|
| Total Current Liabilities |
9
|
13
|
38
|
40
|
41
|
43
|
32
|
32
|
17
|
19
|
22
|
15
|
26
|
13
|
|
| Long-Term Debt |
17
|
22
|
21
|
21
|
6
|
8
|
8
|
11
|
11
|
10
|
10
|
10
|
5
|
9
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
26
N/A
|
35
+36%
|
59
+67%
|
61
+3%
|
47
-22%
|
51
+8%
|
40
-20%
|
43
+6%
|
28
-36%
|
29
+4%
|
32
+10%
|
25
-21%
|
32
+28%
|
23
-29%
|
|
| Equity | |||||||||||||||
| Common Stock |
5
|
5
|
5
|
5
|
12
|
24
|
33
|
33
|
33
|
33
|
33
|
33
|
33
|
33
|
|
| Retained Earnings |
5
|
6
|
6
|
6
|
21
|
11
|
29
|
30
|
30
|
32
|
34
|
39
|
44
|
48
|
|
| Total Equity |
10
N/A
|
11
+4%
|
11
+3%
|
11
+3%
|
33
+192%
|
35
+6%
|
62
+75%
|
63
+2%
|
63
+1%
|
65
+2%
|
67
+3%
|
72
+8%
|
77
+6%
|
81
+6%
|
|
| Total Liabilities & Equity |
36
N/A
|
46
+27%
|
70
+52%
|
72
+3%
|
81
+12%
|
86
+7%
|
102
+19%
|
105
+3%
|
91
-14%
|
93
+2%
|
98
+5%
|
97
-1%
|
109
+12%
|
103
-5%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
2
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
|